DTCT EU 2024 Seminars

7:15AM - 8:00AM

Registration and Networking

8:00AM - 8:15AM

Opening Remarks

Max Partington, Conference Director, AMG World

8:15AM - 8:30AM

Chairman’s Speech

Moving beyond Disruptive Technology: Redefining Technological Value in Clinical Trials

Speaker

  • Daragh Ryan Former Senior Director Janssen Clinical Innovation - The Janssen Pharmaceutical Companies of Johnson & Johnson
8:30AM - 9:00AM

Fostering Clinical Innovation in a Large Pharmaceutical Organisation

Speaker

9:00AM - 9:30AM

Involving the Patient Voice within Clinical Trial Design to Identify User-centric Technology

Speaker

9:30AM - 10:15AM

Technology Demonstrations

This session provides an additional opportunity to meet with our product and solution providers in the exhibition hall to learn more about the products,
technology, and services that have been developed to solve some of your unique challenges. The technology demonstrations will last approximately
8 minutes on four cycles with the opportunity to ask questions immediately afterwards over the refreshment break.
Hear from leading technology leaders specialising in remote monitoring & engagement tools, wearables, data & analytics software, AI/ ML and many more.

10:15AM - 10:45AM

Networking Break and Exhibition

10:45AM - 11:45AM

Roundtable Discussion: Capturing Real-World-Data through Wearable Medical Technology: Gaining a Holistic View of the Effectiveness and Safety of a Clinical Trial

10:45AM - 11:45AM

Roundtable Discussion: Creating a Patient-Data Standardisation Framework to Improve the Exchange, Integration, and Analysis of Patient Data Across Different Healthcare Organisations

Speaker

10:45AM - 11:45AM

Roundtable Discussion: Involving the Patient Voice within Clinical Trial Design to Identify User-centric Technology

Speaker

10:45AM - 11:45AM

Roundtable Discussion: Leveraging Disruptive Technology Whilst Setting Up Clinical Trials: Challenges and Opportunities

Speaker

  • Dr Fabian Kreimendahl Medical Evidence Biostatistics Manager - The Janssen Pharmaceutical Companies of Johnson & Johnson
11:45AM - 12:15PM

Innovations in Data Capture and Enhancing Trial Delivery: Automatically Transforming EHR to EDC Integration

Speaker

12:15PM - 1:15PM

Networking Lunch and Exhibition

1:15PM - 1:45PM

Moving Toward a Unified and Connected Platform for Comprehensive and Seamless Clinical Data Integration

1:45PM - 2:45PM

Roundtable Discussion: How can Digital Biomarkers Replace Clinical Endpoints? Gaining Validation and Regulatory Approval for Digital Biomarkers as Primary Endpoints

Speaker

1:45PM - 2:45PM

Roundtable Discussion: Implementing Advanced Analytics Tools to Leverage Real-World Data and Allow for Deeper Insights into Trial

1:45PM - 2:45PM

Roundtable Discussion: Increasing Trust in Sensor Selection for Clinical Trials

Speakers

1:45PM - 2:45PM

Roundtable Discussion: Utilising Real World Evidence to Support Clinical Trials

Speaker

2:45PM - 3:15PM

Harnessing Synthetic Control Arms for Time & Cost Reduction and Improved Scientific Validity

3:15PM - 3:45PM

Networking Break and Exhibition

3:45PM - 4:45PM

Roundtable Discussion: Creating Data Products in Clinical Trials: Value Created And Implementation Challenges

Speaker

3:45PM - 4:45PM

Roundtable Discussion: Implementing AI for Source Data Verification and Risk- Based Monitoring: Allowing Early Detection of Data Discrepancies for Accurate Clinical Trial Monitoring

3:45PM - 4:45PM

Roundtable Discussion: Prioritising Inclusivity, Patient Needs, and Well-being in Clinical Trial Management

Speaker

  • Nurcan Coskun The Janssen Pharmaceutical Companies of Johnson & JohnsonNurcan Coskun Director, Program Management Leader, PH - The Janssen Pharmaceutical Companies of Johnson & Johnson
3:45PM - 4:45PM

Roundtable Discussion: Utilising Disruptive Technology to Increase Accessibility to More Diversified Patient Pools

4:45PM - 5:30PM

Panel Discussion: Shaping the Future of Clinical Trials through Data-Driven Innovation and Patient-Centric Approaches

Speakers

  • Dr. Christian Müller Head of Data Generation - Bayer
  • Nurcan Coskun The Janssen Pharmaceutical Companies of Johnson & JohnsonNurcan Coskun Director, Program Management Leader, PH - The Janssen Pharmaceutical Companies of Johnson & Johnson
  • Angela May Head DCT Strategy & Implementation - Bayer
5:30PM - 5:40PM

Closing Remarks from AMG World

5:40PM

Networking and Drinks Reception

All attendees are invited to attend our networking drinks reception at the
end of the day’s proceedings. This is our way of saying thank you for your
contribution and to create an additional opportunity to continue your
discussions in an informal setting.

7:15AM - 8:00AM

Registration and Networking

8:00AM - 8:15AM

Opening Remarks

Max Partington, Conference Director, AMG World

8:15AM - 8:30AM

Chairman’s Speech

Moving beyond Disruptive Technology: Redefining Technological Value in Clinical Trials

Speaker

  • Daragh Ryan Former Senior Director Janssen Clinical Innovation - The Janssen Pharmaceutical Companies of Johnson & Johnson
8:30AM - 9:00AM

Fostering Clinical Innovation in a Large Pharmaceutical Organisation

Speaker

9:00AM - 9:30AM

Involving the Patient Voice within Clinical Trial Design to Identify User-centric Technology

Speaker

9:30AM - 10:15AM

Technology Demonstrations

This session provides an additional opportunity to meet with our product and solution providers in the exhibition hall to learn more about the products,
technology, and services that have been developed to solve some of your unique challenges. The technology demonstrations will last approximately
8 minutes on four cycles with the opportunity to ask questions immediately afterwards over the refreshment break.
Hear from leading technology leaders specialising in remote monitoring & engagement tools, wearables, data & analytics software, AI/ ML and many more.

10:15AM - 10:45AM

Networking Break and Exhibition

10:45AM - 11:45AM

Roundtable Discussion: Capturing Real-World-Data through Wearable Medical Technology: Gaining a Holistic View of the Effectiveness and Safety of a Clinical Trial

10:45AM - 11:45AM

Roundtable Discussion: Creating a Patient-Data Standardisation Framework to Improve the Exchange, Integration, and Analysis of Patient Data Across Different Healthcare Organisations

Speaker

10:45AM - 11:45AM

Roundtable Discussion: Involving the Patient Voice within Clinical Trial Design to Identify User-centric Technology

Speaker

10:45AM - 11:45AM

Roundtable Discussion: Leveraging Disruptive Technology Whilst Setting Up Clinical Trials: Challenges and Opportunities

Speaker

  • Dr Fabian Kreimendahl Medical Evidence Biostatistics Manager - The Janssen Pharmaceutical Companies of Johnson & Johnson
11:45AM - 12:15PM

Innovations in Data Capture and Enhancing Trial Delivery: Automatically Transforming EHR to EDC Integration

Speaker

12:15PM - 1:15PM

Networking Lunch and Exhibition

1:15PM - 1:45PM

Moving Toward a Unified and Connected Platform for Comprehensive and Seamless Clinical Data Integration

1:45PM - 2:45PM

Roundtable Discussion: How can Digital Biomarkers Replace Clinical Endpoints? Gaining Validation and Regulatory Approval for Digital Biomarkers as Primary Endpoints

Speaker

1:45PM - 2:45PM

Roundtable Discussion: Implementing Advanced Analytics Tools to Leverage Real-World Data and Allow for Deeper Insights into Trial

1:45PM - 2:45PM

Roundtable Discussion: Increasing Trust in Sensor Selection for Clinical Trials

Speakers

1:45PM - 2:45PM

Roundtable Discussion: Utilising Real World Evidence to Support Clinical Trials

Speaker

2:45PM - 3:15PM

Harnessing Synthetic Control Arms for Time & Cost Reduction and Improved Scientific Validity

3:15PM - 3:45PM

Networking Break and Exhibition

3:45PM - 4:45PM

Roundtable Discussion: Creating Data Products in Clinical Trials: Value Created And Implementation Challenges

Speaker

3:45PM - 4:45PM

Roundtable Discussion: Implementing AI for Source Data Verification and Risk- Based Monitoring: Allowing Early Detection of Data Discrepancies for Accurate Clinical Trial Monitoring

3:45PM - 4:45PM

Roundtable Discussion: Prioritising Inclusivity, Patient Needs, and Well-being in Clinical Trial Management

Speaker

  • Nurcan Coskun The Janssen Pharmaceutical Companies of Johnson & JohnsonNurcan Coskun Director, Program Management Leader, PH - The Janssen Pharmaceutical Companies of Johnson & Johnson
3:45PM - 4:45PM

Roundtable Discussion: Utilising Disruptive Technology to Increase Accessibility to More Diversified Patient Pools

4:45PM - 5:30PM

Panel Discussion: Shaping the Future of Clinical Trials through Data-Driven Innovation and Patient-Centric Approaches

Speakers

  • Dr. Christian Müller Head of Data Generation - Bayer
  • Nurcan Coskun The Janssen Pharmaceutical Companies of Johnson & JohnsonNurcan Coskun Director, Program Management Leader, PH - The Janssen Pharmaceutical Companies of Johnson & Johnson
  • Angela May Head DCT Strategy & Implementation - Bayer
5:30PM - 5:40PM

Closing Remarks from AMG World

5:40PM

Networking and Drinks Reception

All attendees are invited to attend our networking drinks reception at the
end of the day’s proceedings. This is our way of saying thank you for your
contribution and to create an additional opportunity to continue your
discussions in an informal setting.